Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.57 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.57 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.38 |
| ▸ | SELE | P16581 | 1/20 | 0.38 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2077933 | 0.81 | EHMT2 (0.50) | EHMT2EHMT1APOBEC3GRAB9AL3MBTL1 | |
| SCHEMBL19743385 | 0.79 | EHMT2 (0.64) | EHMT2EHMT1APOBEC3GRAB9AL3MBTL1 | |
| SCHEMBL30195130 | 0.76 | EHMT2 (0.59) | EHMT2EHMT1APOBEC3GRAB9AL3MBTL1 | |
| SCHEMBL28579828 | 0.76 | EHMT2 (0.59) | EHMT2EHMT1APOBEC3GRAB9AL3MBTL1 | |
| SCHEMBL423720 | 0.76 | EHMT2 (0.59) | EHMT2EHMT1APOBEC3GRAB9AL3MBTL1 | |
| Methyl Alcohol SCHEMBL28484914 | 0.75 | EHMT2 (0.90) | EHMT2EHMT1APOBEC3GRAB9AL3MBTL1 | |
| SCHEMBL29349787 | 0.75 | EHMT2 (1.00) | EHMT2EHMT1APOBEC3GRAB9AL3MBTL1 | |
| SCHEMBL27972393 | 0.75 | EHMT2 (1.00) | EHMT2EHMT1APOBEC3GRAB9AL3MBTL1 | |
| SCHEMBL21174 | 0.75 | EHMT2 (1.00) | EHMT2EHMT1APOBEC3GRAB9AL3MBTL1 | |
| Ethylamine SCHEMBL18229941 | 0.75 | EHMT2 (0.71) | EHMT2EHMT1APOBEC3GRAB9AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3031447-B1 | NUCLEIC ACID-ENCAPSULATING POLYMER MICELLE COMPLEX AND METHOD FOR PRODUCING SAME | JAPAN SCIENCE & TECH AGENCY (JP) | 2019-12-25 | — | — | EP | disclosed |
| US-20160184457-A1 | NUCLEIC ACID-ENCAPSULATING POLYMER MICELLE COMPLEX AND METHOD FOR PRODUCING SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2016-06-30 | — | — | US | disclosed |
| EP-3031447-A1 | NUCLEIC ACID-ENCAPSULATING POLYMER MICELLE COMPLEX AND METHOD FOR PRODUCING SAME | Japan Science and Technology Agency (JP) | 2016-06-15 | — | — | EP | disclosed |
| EP-0786006-B1 | CEPHALOSPORIN C AMIDOHYDROLASE, PRODUCTION AND USE | GLAXO GROUP LTD (GB) | 2005-09-28 | — | — | EP | disclosed |
| WO-2002083951-A1 | MULTIPLEXED LIGAND/PROTEIN BINDING ASSAYS WITH PNA LABELS | NORTHEASTERN UNIVERSITY (US) | 2002-10-24 | — | — | WO | disclosed |
| US-6297032-B1 | EXPRESSING ENZYME ASSOCIATED WITH THE DEGRADATION OF PREFERENTIAL ANTIBIOTIC; TRANSFORM AND CULTURE CELLS, RECOVER PREFERENTIAL PROTEIN | GLAXO GROUP LIMITED (GB) | 2001-10-02 | — | — | US | disclosed |
| US-5919648-A | ONE STEP CONVERSION OF CEPHALOSPORIN C OR DERIVATIVE INTO 7-AMINOCEPHALOSPORANIC ACID OR DERIVATIVE USING AMINOHYDROLASE FROM PSUEDOMONAS VESICULARIS B965; FOR CEPHALOTHIN, CEPHALORIDINE, AND CEFUROXIME SYNTHESIS | GLAXO GROUP LIMITED (GB) | 1999-07-06 | — | — | US | disclosed |
| EP-0786006-A2 | CEPHALOSPORIN C AMIDOHYDROLASE, PRODUCTION AND USE | GLAXO GROUP LIMITED (GB) | 1997-07-30 | — | — | EP | disclosed |
| WO-1996016174-A2 | CEPHALOSPORIN C AMIDOHYDROLASE, PRODUCTION AND USE | GLAXO GROUP LIMITED (GB) | 1996-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160184457-A1 | NUCLEIC ACID-ENCAPSULATING POLYMER MICELLE COMPLEX AND METHOD FOR PRODUCING SAME | POLM, DNA2, POLRMT | EHMT2 2263/4885EHMT1 2821/4885APOBEC3G 1703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.